| Literature DB >> 33773573 |
Tuyen T H Do1,2,3, Tran N B Lai1,2, Steven L Stephenson4, Hanh T M Tran5,6.
Abstract
BACKGROUND: Microbial polysaccharides have been reported to possess remarkable bioactivities. Physarum polycephalum is a species of slime mold for which the microplasmodia are capable of rapid growth and can produce a significant amount of cell wall-less biomass. There has been a limited understanding of the polysaccharides produced by microplasmodia of slime molds, including P. polycephalum. Thus, the primary objectives of this research were first to chemically characterize the exopolysaccharides (EPS) and intracellular polysaccharides (IPS) of P. polycephalum microplasmodia and then to evaluate their cytotoxicity against several cancer cell lines.Entities:
Keywords: Cytotoxicity; HeLa; MCF-7; Microplasmodia; Physarum polycephalum; Polysaccharides
Mesh:
Substances:
Year: 2021 PMID: 33773573 PMCID: PMC8005236 DOI: 10.1186/s12896-021-00688-5
Source DB: PubMed Journal: BMC Biotechnol ISSN: 1472-6750 Impact factor: 2.563
Yields of different types of polysaccharide from P. polycephalum
| Parameter | Amount (g/l) |
|---|---|
| Crude EPS | 4.43a ± 0.44 |
| Partially purified EPS | 2.95a |
| Crude IPS | **3.46a ± 0.36 (0.30 g/g dried biomass) |
| Partially purified IPS | **2.45a ± 0.36 (0.21 g/g dried biomass) |
**indicates the amount of the intracellular polysaccharides obtained from one liter of the culture medium (g/l). These figures were calculated based on their contents in one gram of the dried biomass (data inside the brackets), and the total dried biomass obtained from one liter of the culture medium*. The same letter (a) indicates insignificant difference (p > 0.05)
Percentages of major chemical components of the polysaccharide samples from P. polycephalum microplasmodia
| Sample | Total carbohydrate content (%) | Total protein content (%) | Total sulfate group content (%) | Total percentages |
|---|---|---|---|---|
| Crude EPS | 44.26a ± 0.70 | 3.26c ± 0.33 | 2.04 ± 0.02 | 49.56 |
| Partially purified EPS | 56.61a ± 5.73 | 1.16b ± 0.20 | ND | 57.77 |
| Crude IPS | 63.38ab ± 0.60 | 2.71c ± 0.39 | 0.14 ± 0.02 | 66.23 |
| Partially purified IPS | 80.40b ± 14.61 | 0.57a ± 0.27 | ND | 80.97 |
ND not detected; Different letters (a, b, c, d) imply significant differences (p < 0.05); Total percentages: were calculated by adding together the contents of carbohydrate, protein, and sulfate (if any) detected in each sample
Fig. 1FTIR spectral analysis of the crude EPS (a), partially purified EPS (b), crude IPS (c); partially purified IPS (d)
Monosaccharide composition of the partially purified polysaccharide samples from P. polycephalum microplasmodia
| Sample | Monosaccharide composition (%) | |||
|---|---|---|---|---|
| Glucose | Galactose | Mannose | Rhamnose | |
| Partially purified EPS | 13.84 ± 0.16 | 5.70 ± 0.15 | 0.24 ± 0.012 | |
| Partially purified IPS | 13.22 ± 0.20 | 0.23 ± 0.0071 | 0.09 ± 0.0045 | |
Fig. 2The PMP-RP-HPLC-UV chromatograms of monosaccharide analysis on the partially purified EPS (a), IPS (b), and sugar standard mixture (c)
Fig. 3The molecular weight distributions of polysaccharide molecules in the partially purified EPS (a) and IPS (b)
Molecular Weight (Mw), Number-Average Molecular Weight (Mn) and Polydispersity Index (PI) of P. polycephalum microplasmodial polysaccharides
| Sample | Number weighted molecular weight (M | Mass-weighted molecular weight (M | Polydispersity (M |
|---|---|---|---|
| Partially purified EPS | 9570 kDa | 14,762 kDa | 1.542 |
| Partially purified IPS | 565 kDa | 1788 kDa | 3.160 |
Fig. 4Percentages of viable HeLa (a), MCF-7 (b), HepG2 (c) and BAE cells (d) treated with 1 mg/ml polysaccharide samples. Doxorubicin (dox) 50 μg/ml was used as a positive control. Data represent the mean and standard deviation. Note that ‘cr-‘= crude sample and ‘pp-‘= partially purified sample.* indicates a significant difference as compared with the control (p < 0.05)
Fig. 5Distribution of cells in the subG1, Go/G1, S and G2/M phases of HeLa cells treated with partially purified IPS 1 mg/ml. *indicates a significant difference as compared with the control (p < 0.05). PBS solution was used as negative control. Data represent the mean and standard deviation
Fig. 6Distribution of cells in the subG1, Go/G1, S and G2/M phases of